• Library
  • Intranet
Albert Einstein College of Medicine
  • About
  • Education
  • Research
  • Departments & Centers
Giving
Search
Menu
Montefiore Health System
  • Faculty Directory
  • Research Connections
  • Faculty Directory
  • Research Connections
Information For
  • Alumni
  • Donors
  • Faculty
  • Postdocs
  • Students (Prospective, Current)
  • Visitors
Quick Links
  • About
  • Administration
  • Careers
  • Departments & Centers
  • Directory
  • Education & Admissions
  • Events
  • Find Faculty
  • Giving
  • Health
  • Intranet
  • Library
  • Research
  • Webmail
News & Media
  • Newsroom
  • Blog
  • Einstein in the News
  • Expert List for Media
  • Features
  • Magazine
  • Multimedia
  • News Releases
  • Research Briefs
  • Social Media Hub

Faculty Profile

  • Home
  • Faculty Directory
  • Xingxing Zang, Ph.D.

Xingxing Zang, Ph.D.

Xingxing Zang

Professor, Department of Microbiology & Immunology

Professor, Department of Oncology (Medical Oncology)

Professor, Department of Medicine (Oncology & Hematology)

Professor, Department of Urology

Louis Goldstein Swan Chair in Women's Cancer Research

Area of Research: New T cell immune checkpoints; Cancer immunotherapy; Autoimmune diseases and immunotherapy; Metabolic diseases and immunotherapy; Infection and vaccines

Contact Information

718.430.4155718.430.8711xingxing.zang@einsteinmed.edu

Albert Einstein College of Medicine
Jack and Pearl Resnick Campus

1300 Morris Park Avenue
Forchheimer Building, Room 405A
Bronx, NY 10461

Research Profiles

More Resources: Zang Immune Checkpoint and Immunotherapy Lab website

Is this your profile? Edit profile

Professional Interests

The immune system is determined by both positive costimulation and negative coinhibition, generated mainly by the interaction between the B7 ligand family and their receptor CD28 family. We  discovered new members of the T cell costimulatory/coinhibitory B7 family and CD28 family including B7x, HHLA2 and TMIGD2,  discovered the HHLA2-KIR3DL3 immunosuppressive pathway,  discovered the HHLA2-TMIGD2 immunostimulatory pathway, demonstrated the biology and therapeutic potential of the KIR2DL5-PVR pathway, and significantly contributed to other immune checkpoints B7-H3, Tim-3, ICOS, PD-L1/PD-1, BTNL2, etc. We are using a variety of experimental approaches (gene knock-out/transgenic mice, humanized mice, monoclonal antibodies, single-cell RNA sequencing, protein/cell engineering, structure, patients samples, in vitro/in vivo imaging, bioinformatics, etc) to understand how new immune checkpoints regulate T cells and other immune cells. 

Current emphasis in the lab is placed in the following areas: 1) Fundamental biology of new immune checkpint pathways; 2) Translational immunotherapies in cancers, autoimmune diseases, metabolic diseases.  

A new immune checkpoint inhibitor from our lab  is currently in nine clinical trials of phase II and I/II  in 695 patients with 8 different types of advanced solid cancers (nasopharyngeal cancer, head and neck cancer, hepatocellular carcinoma, non-small cell lung cancer, small cell lung cancer,  esophageal cancer, melanoma, colorectal cancer) and 3 different types of recurrent/refractory hematologic cancers (acute myeloid leukemia, myelodysplastic syndromes, lymphoma).

Another novel first-in-class immune checkpoint inhibitor from our lab is currently in phase I, multicenter (Massachusetts General Hospital, MD Anderson Cancer Center, Johns Hopkins University, Montefiore Einstein Cancer Center, Sarah Cannon Research Institute, NEXT Oncology-San Antonio), first-in-human clinical trial in 131 patients with 12 different types of metastatic solid cancers (pancreatic cancer, cholangiocarcinoma, renal cell carcinoma, non-small cell lung cancer, triple negative breast cancer, prostate cancer, colorectal cancer, urothelial carcinoma, gastric gastroesophageal carcinoma, endometrial cancer, cervical cancer, osteosarcoma). 

Our research has formed scientific foundation and core intellectual property for several drug companies.

Since 2008 the lab has mentored 51 trainees of MD-PhD or PhD students, postdoctoral fellows, clinical fellows, and visiting scientists. Most of trainees have subsequently moved on to independent careers in academic universities, medical centers, biopharmaceutical industry, and US government agencies.

 

Zang Lab website:

https://www.xingxingzanglab.org

 

 

 

 

Related News

More News

  • Translating Discoveries into Therapies
    Einstein Magazine
    Translating Discoveries into Therapies

    Jun 09, 2023

  • Developing Novel Immune Checkpoint Inhibitors Against Bladder Cancer
    Research Brief
    Developing Novel Immune Checkpoint Inhibitors Against Bladder Cancer

    Jan 05, 2023

  • Einstein Researchers Develop Promising New Cancer Therapy
    News Release
    Einstein Researchers Develop Promising New Cancer Therapy

    Nov 15, 2022

  • Montefiore Einstein Cancer Center Researchers Receive Price Family Foundation Health Equity Research Awards
    News Release
    Montefiore Einstein Cancer Center Researchers Receive Price Family Foundation Health Equity Research Awards

    May 19, 2022

Albert Einstein College of Medicine
Jack and Pearl Resnick Campus
1300 Morris Park Avenue
Bronx, NY 10461
718.430.2000
Affiliated With
Montefiore Health
Yeshiva University
  • About Einstein
    • History
    • Dean's Page
    Administration
    • Administrative Departments
    Alumni
    Careers
  • Centers (Research)
    Contact Us
    Departments
    Diversity
    • Report a Bias Incident
    Donors
    • Giving to Einstein
  • Education
    • Graduate Medical Education (G.M.E.)
    • Graduate Program (Ph.D.)
    • Master of Science in Bioethics (M.B.E.)
    • Master of Science in Clinical Research Methods (M.S.)
    • Medical Program (M.D.)
    • MSTP Program (M.D. - Ph.D.)
  • Einstein Senate
    Faculty Directory
    Health
    • Affiliated Institutions
    • Clinical Programs
    • Global Health
    • E-M Partnership
    INTRANET
    Library
    Luminis Portal
  • Newsroom
    • Blog
    • Einstein in the News
    • Expert List for Media
    • Features
    • Magazine
    • Multimedia
    • News Releases
    • Research Briefs
    • Social Media Hub
  • Policies
    Research
    • Collaboration Zone
    • Scientific Resources
    Video
    Visitors
    • Campus Map
    • Directions
    Webmail
ALBERT EINSTEIN ®
College of Medicine
© Albert Einstein College of Medicine | Privacy Policy | Terms of Use | Webmaster